These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 9362387)

  • 1. Dose-finding study of interferon alfa-n3 in hepatitis C.
    Hoofnagle JH; Everhart J
    Hepatology; 1997 Nov; 26(5):1366-7. PubMed ID: 9362387
    [No Abstract]   [Full Text] [Related]  

  • 2. [Therapeutic response to alpha-interferon in chronic alcoholics with viral hepatitis C].
    Nikitin IG; Kuznetsov SL; Liuliaeva OD; Storozhakov GI; Kisliakov VA; Uskov IuI
    Klin Med (Mosk); 1998; 76(8):33-5. PubMed ID: 9770965
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [How should hepatitis C be treated? Treatment of hepatitis C with interferon].
    Marcellin P
    Gastroenterol Clin Biol; 1997; 21(1 Pt 2):S81-8. PubMed ID: 9161518
    [No Abstract]   [Full Text] [Related]  

  • 4. [Should hepatitis C be treated? Which biological tests are useful before deciding or refuting a treatment with interferon-alpha in patients with chronic hepatitis C?].
    Pawlotsky JM
    Gastroenterol Clin Biol; 1997; 21(1 Pt 2):S41-50. PubMed ID: 9161513
    [No Abstract]   [Full Text] [Related]  

  • 5. [Treatment of chronic hepatitis C. Many interrogatives and some answers].
    Ampurdanès S; Rodés J
    Rev Clin Esp; 1996 Oct; 196(10):667-9. PubMed ID: 9005467
    [No Abstract]   [Full Text] [Related]  

  • 6. [Chronic hepatitis C: therapeutic uncertainties].
    Blondon H; Bergmann JF
    Gastroenterol Clin Biol; 1996; 20(12):1043-6. PubMed ID: 9033847
    [No Abstract]   [Full Text] [Related]  

  • 7. Natural leukocyte interferon alfa for the treatment of chronic viral hepatitis in heart transplant recipients.
    Fagiuoli S; Pevere S; Minniti F; Livi U; Caforio AL; Naccarato R; Chiaramonte M
    Transplantation; 2003 Apr; 75(7):982-6. PubMed ID: 12698084
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Monitoring of treated or non-treated chronic viral hepatitis C. 2: Criteria of efficacy and monitoring of treatment with interferon-alpha].
    Payen JL
    Gastroenterol Clin Biol; 1997; 21(1 Pt 2):S175-89. PubMed ID: 9161529
    [No Abstract]   [Full Text] [Related]  

  • 9. [Results of treatment of hepatitis C with interferon alone or combined with other drugs].
    Serfaty L
    Gastroenterol Clin Biol; 1997; 21(1 Pt 2):S154-66. PubMed ID: 9161527
    [No Abstract]   [Full Text] [Related]  

  • 10. Hepatitis C: limits and dose regimen of interferon alfa.
    Prescrire Int; 1998 Oct; 7(37):150-4. PubMed ID: 10915423
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [How should hepatitis C be monitored? Monitoring of treated hepatitis C].
    Larrey D
    Gastroenterol Clin Biol; 1997; 21(1 Pt 2):S99-110. PubMed ID: 9161521
    [No Abstract]   [Full Text] [Related]  

  • 12. Clinical use of interferons in hepatology.
    Civeira MP
    Methods Find Exp Clin Pharmacol; 1996; 18 Suppl B():33-4. PubMed ID: 8899691
    [No Abstract]   [Full Text] [Related]  

  • 13. Hepatitis C virus dynamics in vivo: effect of ribavirin and interferon alfa on viral turnover.
    Zeuzem S; Schmidt JM; Lee JH; von Wagner M; Teuber G; Roth WK
    Hepatology; 1998 Jul; 28(1):245-52. PubMed ID: 9657119
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [How to follow treated and untreated chronic hepatitis B and C].
    Adler M; Golstein P; Botembe N; Bourgeois N
    Rev Med Brux; 1997 Sep; 18(4):183-6. PubMed ID: 9411639
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Dysthyroidism and interferon-alpha: the withdrawal of interferon should not be systematic].
    Chédin P; Cahen-Varsaux J; Demmane S
    Gastroenterol Clin Biol; 1995 Apr; 19(4):442-4. PubMed ID: 7672530
    [No Abstract]   [Full Text] [Related]  

  • 16. [Lichen planus and hepatitis C. Heterogeneity in the course of 6 cases treated with interferon alpha].
    Doutre MS; Couzigou P; Beylot-Barry M; Beylot C; Quinton A
    Gastroenterol Clin Biol; 1996; 20(8-9):709-10. PubMed ID: 8977825
    [No Abstract]   [Full Text] [Related]  

  • 17. A rational approach to hepatitis C.
    Mills P; McPeake J; McCruden E
    Practitioner; 1996 Mar; 240(1560):172-6. PubMed ID: 8710731
    [No Abstract]   [Full Text] [Related]  

  • 18. Sequential versus concomitant administration of ribavirin and interferon alfa-n3 in patients with chronic hepatitis C not responding to interferon alone: results of a randomized, controlled trial.
    Sostegni R; Ghisetti V; Pittaluga F; Marchiaro G; Rocca G; Borghesio E; Rizzetto M; Saracco G
    Hepatology; 1998 Aug; 28(2):341-6. PubMed ID: 9695995
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Should hepatitis C be treated? What are indications of treatment in chronic hepatitis C?].
    Pascal JP
    Gastroenterol Clin Biol; 1997; 21(1 Pt 2):S70-9. PubMed ID: 9161517
    [No Abstract]   [Full Text] [Related]  

  • 20. [Hepatitis C: screening and treatment].
    Gastroenterol Clin Biol; 1997; 21(1 Pt 2):S202-11. PubMed ID: 9161531
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.